Sumitomo Mitsui Trust Group Portfolio holdings
Sumitomo Mitsui Trust Group, Inc., originally founded in 1924 as Sumitomo Trust Co., Ltd., and headquartered in Tokyo, Japan, is a major Japanese financial holding company that evolved through the 2011 merger of Chuo Mitsui Trust Holdings and Sumitomo Trust and Banking Co., Ltd., forming its core entity, Sumitomo Mitsui Trust Bank. Renamed from Sumitomo Mitsui Trust Holdings in October 2024, it is Japan’s largest trust bank and fifth-largest bank by assets, managing hundreds of billions through services like trust banking, asset management, real estate, and financial brokerage for retail and institutional clients. Distinct from the Sumitomo Mitsui Financial Group despite shared historical roots in the Sumitomo and Mitsui conglomerates, the group emphasizes sustainability and long-term client solutions, operating globally with subsidiaries in cities like New York, London, and Hong Kong. Under leaders like Chairman Kazuo Ohmori, it blends a century-long legacy with modern financial innovation, focusing on pension funds, real estate trusts, and ESG-driven investments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$180M |
| 2 |
Alibaba
BABA
|
+$155M |
| 3 |
Truist Financial
TFC
|
+$122M |
| 4 |
Blackstone
BX
|
+$118M |
| 5 |
Pinterest
PINS
|
+$61.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$289M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$116M |
| 3 |
Apple
AAPL
|
+$79.4M |
| 4 |
Tesla
TSLA
|
+$71.8M |
| 5 |
Pinduoduo
PDD
|
+$47.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.71% |
| 2 | Financials | 15.26% |
| 3 | Healthcare | 13.27% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
US Bancorp
USB
$99.6B
| $349M | 0.27% |
5,888,418
+55,609
| +1% | +$3.22M |
|
77
Booking.com
BKNG
$138B
| $344M | 0.27% |
4,185,800
-161,000
| -4% | -$12.6M |
|
78
Intuit
INTU
$81.1B
| $342M | 0.27% |
1,308,694
-78,021
| -6% | -$20.4M |
|
79
Gilead Sciences
GILD
$161B
| $340M | 0.27% |
5,232,301
+77,087
| +1% | +$5.02M |
|
80
Fidelity National Information Services
FIS
$21.5B
| $339M | 0.27% |
2,440,501
+43,801
| +2% | +$5.87M |
|
81
Goldman Sachs
GS
$313B
| $334M | 0.26% |
1,453,494
+2,322
| +0.2% | +$504K |
|
82
United Parcel Service
UPS
$97.6B
| $321M | 0.25% |
2,739,460
+106,126
| +4% | +$12.6M |
|
83
Charter Communications
CHTR
$14.7B
| $318M | 0.25% |
655,925
+7,643
| +1% | +$3.52M |
|
84
Cigna
CI
$76.6B
| $308M | 0.24% |
1,507,949
+9,656
| +0.6% | +$1.77M |
|
85
CME Group
CME
$92.2B
| $308M | 0.24% |
1,534,987
+40,750
| +3% | +$8.36M |
|
86
ConocoPhillips
COP
$147B
| $308M | 0.24% |
4,735,897
-90,814
| -2% | -$5.34M |
|
87
Mondelez International
MDLZ
$77.7B
| $306M | 0.24% |
5,554,443
+80,871
| +1% | +$4.33M |
|
88
Automatic Data Processing
ADP
$100B
| $301M | 0.24% |
1,765,492
+4,277
| +0.2% | +$708K |
|
89
Prologis
PLD
$138B
| $297M | 0.23% |
3,328,306
+193,512
| +6% | +$17.2M |
|
90
Target
TGT
$62.1B
| $291M | 0.23% |
2,272,626
+106,122
| +5% | +$12.5M |
|
91
Duke Energy
DUK
$102B
| $290M | 0.23% |
3,176,204
+41,115
| +1% | +$3.77M |
|
|
92
Truist Financial
TFC
$63.2B
| $289M | 0.23% |
5,137,483
+2,256,649
| +78% | +$122M |
|
93
Enbridge
ENB
$124B
| $289M | 0.23% |
7,259,930
+110,830
| +2% | +$4.14M |
|
94
Becton Dickinson
BDX
$43.1B
| $286M | 0.22% |
1,077,702
+19,000
| +2% | +$4.74M |
|
95
Southern Company
SO
$110B
| $285M | 0.22% |
4,477,026
+237,829
| +6% | +$14.7M |
|
96
Intuitive Surgical
ISRG
$121B
| $281M | 0.22% |
1,424,994
+339
| +0% | +$63.5K |
|
97
Stryker
SYK
$127B
| $280M | 0.22% |
1,333,479
+19,021
| +1% | +$3.95M |
|
98
Intercontinental Exchange
ICE
$82.4B
| $275M | 0.22% |
2,972,565
+71,044
| +2% | +$6.59M |
|
99
PNC Financial Services
PNC
$100B
| $272M | 0.21% |
1,717,941
-151,110
| -8% | -$22.7M |
|
100
Vertex Pharmaceuticals
VRTX
$121B
| $272M | 0.21% |
1,242,096
+20,672
| +2% | +$4.18M |
|
Similar funds
Sumitomo Mitsui Trust Group's Q4 2019 Portfolio in Review
As of Q4 2019, Sumitomo Mitsui Trust Group held 1,139 positions worth $127B, up 11% from $115B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Sumitomo Mitsui Trust Group's Q4 2019 filing shows 70 new, 686 increased, 308 reduced and 53 closed positions. Its largest new stake was Bio-Techne: 951,116 shares worth $52.2M. The largest sale was Celgene Corp, an estimated $289M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Sumitomo Mitsui Trust Group's largest Q4 2019 buy was Bio-Techne: 951,116 shares worth $52.2M.
- Sumitomo Mitsui Trust Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $180M increase.
- Sumitomo Mitsui Trust Group's biggest Q4 2019 reduction was Apple, cutting an estimated $79.4M.
- Sumitomo Mitsui Trust Group fully exited Celgene Corp in Q4 2019, selling an estimated $289M.
- Sumitomo Mitsui Trust Group's ten largest holdings make up 19% of its $127B portfolio in Q4 2019.
- Sumitomo Mitsui Trust Group opened 70 new positions and closed 53 in Q4 2019.
- Sumitomo Mitsui Trust Group's portfolio value rose 11% quarter-over-quarter to $127B.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2019, filed 31 Jan 2020.